Table 3.
Budget impact analysis of direct medical costs in the base-case analysis, presented in million THB (million US$ in parentheses)
| Strategy | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | 5-year cumulative |
| 1 (PEP ID using PCEC) |
2.7 (0.08) |
5.3 (0.15) |
8.0 (0.23) |
10.7 (0.30) |
13.4 (0.38) |
40.1 (1.14) |
| 2 (PEP ID using CPRV/PVRV) |
2.9 (0.08) |
5.7 (0.16) |
8.6 (0.24) |
11.4 (0.32) |
14.3 (0.40) |
42.9 (1.21) |
| 3 (PEP IM using CPRV/PVRV) |
3.3 (0.09) |
6.7 (0.19) |
10.0 (0.28) |
13.4 (0.38) |
16.7 (0.47) |
50.2 (1.42) |
| 4 (PEP IM using PCEC) |
3.4 (0.10) |
6.8 (0.19) |
10.2 (0.29) |
13.6 (0.39) |
17.0 (0.48) |
51.1 (1.45) |
| 5 (PrEP+PEP ID using PCEC) |
21.1 (0.60) |
42.1 (1.19) |
62.7 (1.78) |
83.1 (2.36) |
103.3 (2.93) |
312.4 (8.85) |
| 6 (PrEP+PEP ID using CPRV/PVRV) |
23.3 (0.66) |
46.3 (1.31) |
69.0 (1.95) |
91.5 (2.59) |
113.7 (3.22) |
343.7 (9.72) |
| 7 (PrEP+PEP IM using CPRV/PVRV) |
30.1 (0.85) |
59.9 (1.70) |
89.5 (2.53) |
118.8 (3.36) |
147.9 (4.19) |
446.2 (12.63) |
| 8 (PrEP+PEP IM using PCEC) |
30.9 (0.88) |
61.6 (1.74) |
92.0 (2.61) |
122.1 (3.46) |
152.0 (4.31) |
458.6 (12.99) |
CPRV, chromatographically purified Vero cell vaccine; ID, intradermal; IM, intramuscular; PCEC, purified chick embryo cell vaccine; PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis; PVRV, purified Vero cell rabies vaccine; THB, Thai Baht; US$, United States dollar.